Glypican-3 Immunohistochemistry Kits

About Biomosaics

BioMosaics is a private, revenue-generating diagnostics company focused on the Glypican-3 (GPC3) biomarker for liver cancer. The company commercializes a suite of validated antibodies and immunoassays, including its CanAg® EIA, primarily for research and clinical diagnostic use. With a leadership team experienced in biotechnology and academic research, and key scientific partnerships, BioMosaics positions itself as a quality provider in the niche GPC3 diagnostics space. The company's products support the broader therapeutic development landscape targeting GPC3 in oncology.

Therapeutic Areas

Other Detection of GPC3 in tissue samples Drugs